Conservative Surgical Therapy for Leydig Cell Tumor

Luca Carmignani, Renzo Colombo, Franco Gadda, Giacomo Galasso, Andrea Lania, Juan Palou, Ferran Algaba, Humberto Villavicencio, Giovanni Maria Colpi, Ottavio Decobelli, Roberto Salvioni, Giorgio Pizzocaro, Patrizio Rigatti, Francesco Rocco

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Purpose: We performed a long-term evaluation of conservative surgical treatment of benign Leydig cell tumor. Materials and Methods: A multicenter retrospective clinical study was performed at 6 European centers. Case files of all patients diagnosed with Leydig cell tumor and treated with conservative surgery were examined. Patients underwent physical examination, hormone and tumor marker assays, scrotal and abdominal ultrasound, chest x-ray, and an endocrinological examination. Results: From 1987 to 2006, 22 patients with Leydig cell tumor underwent conservative surgery. Mean patient age was 35 years (range 5 to 61). Mean followup was 47 months (range 1 to 230). No local recurrence or metastasis was observed. Patients presented with a palpable testicular nodule (3 patients, 13.7%) or a nodule diagnosed by ultrasound (15 patients, 68.2%), gynecomastia (2 patients, 9.1%), precocious pseudopuberty (1 patient, 4.5%) or scrotal pain (1 patient, 4.5%). Three patients were monorchid after contralateral orchiectomy for inguinal hernia repair (1 patient, 28 years before surgery) and nonseminomatous germ cell tumor (2 patients, 1 month and 6 years before surgery). Diagnosis after frozen section examination was Leydig cell tumor in 20 of 22 cases (91.0%). Mean histological size of the nodule was 1.11 cm (range 0.5 to 2.5). Preoperative FSH and LH levels were high in 4 patients. Tumor markers were normal before and after surgery. Followup was conducted for all patients every 3 to 6 months with physical examination, tumor markers, scrotal and abdominal ultrasound, chest x-ray. Six patients (27.3%) underwent abdominal computerized tomography. Conclusions: When diagnosed early Leydig cell tumors present a favorable followup. In select cases with motivated patients, conservative surgery proved to be a feasible and safe choice.

Original languageEnglish
Pages (from-to)507-511
Number of pages5
JournalJournal of Urology
Volume178
Issue number2
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Leydig Cell Tumor
Tumor Biomarkers
Conservative Treatment
Physical Examination
Thorax
X-Rays
Gynecomastia

Keywords

  • early diagnosis
  • Leydig cell tumor
  • prognosis

ASJC Scopus subject areas

  • Urology

Cite this

Conservative Surgical Therapy for Leydig Cell Tumor. / Carmignani, Luca; Colombo, Renzo; Gadda, Franco; Galasso, Giacomo; Lania, Andrea; Palou, Juan; Algaba, Ferran; Villavicencio, Humberto; Colpi, Giovanni Maria; Decobelli, Ottavio; Salvioni, Roberto; Pizzocaro, Giorgio; Rigatti, Patrizio; Rocco, Francesco.

In: Journal of Urology, Vol. 178, No. 2, 08.2007, p. 507-511.

Research output: Contribution to journalArticle

Carmignani, L, Colombo, R, Gadda, F, Galasso, G, Lania, A, Palou, J, Algaba, F, Villavicencio, H, Colpi, GM, Decobelli, O, Salvioni, R, Pizzocaro, G, Rigatti, P & Rocco, F 2007, 'Conservative Surgical Therapy for Leydig Cell Tumor', Journal of Urology, vol. 178, no. 2, pp. 507-511. https://doi.org/10.1016/j.juro.2007.03.108
Carmignani, Luca ; Colombo, Renzo ; Gadda, Franco ; Galasso, Giacomo ; Lania, Andrea ; Palou, Juan ; Algaba, Ferran ; Villavicencio, Humberto ; Colpi, Giovanni Maria ; Decobelli, Ottavio ; Salvioni, Roberto ; Pizzocaro, Giorgio ; Rigatti, Patrizio ; Rocco, Francesco. / Conservative Surgical Therapy for Leydig Cell Tumor. In: Journal of Urology. 2007 ; Vol. 178, No. 2. pp. 507-511.
@article{6e05eaa4a38f474faf72a218e6980afa,
title = "Conservative Surgical Therapy for Leydig Cell Tumor",
abstract = "Purpose: We performed a long-term evaluation of conservative surgical treatment of benign Leydig cell tumor. Materials and Methods: A multicenter retrospective clinical study was performed at 6 European centers. Case files of all patients diagnosed with Leydig cell tumor and treated with conservative surgery were examined. Patients underwent physical examination, hormone and tumor marker assays, scrotal and abdominal ultrasound, chest x-ray, and an endocrinological examination. Results: From 1987 to 2006, 22 patients with Leydig cell tumor underwent conservative surgery. Mean patient age was 35 years (range 5 to 61). Mean followup was 47 months (range 1 to 230). No local recurrence or metastasis was observed. Patients presented with a palpable testicular nodule (3 patients, 13.7{\%}) or a nodule diagnosed by ultrasound (15 patients, 68.2{\%}), gynecomastia (2 patients, 9.1{\%}), precocious pseudopuberty (1 patient, 4.5{\%}) or scrotal pain (1 patient, 4.5{\%}). Three patients were monorchid after contralateral orchiectomy for inguinal hernia repair (1 patient, 28 years before surgery) and nonseminomatous germ cell tumor (2 patients, 1 month and 6 years before surgery). Diagnosis after frozen section examination was Leydig cell tumor in 20 of 22 cases (91.0{\%}). Mean histological size of the nodule was 1.11 cm (range 0.5 to 2.5). Preoperative FSH and LH levels were high in 4 patients. Tumor markers were normal before and after surgery. Followup was conducted for all patients every 3 to 6 months with physical examination, tumor markers, scrotal and abdominal ultrasound, chest x-ray. Six patients (27.3{\%}) underwent abdominal computerized tomography. Conclusions: When diagnosed early Leydig cell tumors present a favorable followup. In select cases with motivated patients, conservative surgery proved to be a feasible and safe choice.",
keywords = "early diagnosis, Leydig cell tumor, prognosis",
author = "Luca Carmignani and Renzo Colombo and Franco Gadda and Giacomo Galasso and Andrea Lania and Juan Palou and Ferran Algaba and Humberto Villavicencio and Colpi, {Giovanni Maria} and Ottavio Decobelli and Roberto Salvioni and Giorgio Pizzocaro and Patrizio Rigatti and Francesco Rocco",
year = "2007",
month = "8",
doi = "10.1016/j.juro.2007.03.108",
language = "English",
volume = "178",
pages = "507--511",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Conservative Surgical Therapy for Leydig Cell Tumor

AU - Carmignani, Luca

AU - Colombo, Renzo

AU - Gadda, Franco

AU - Galasso, Giacomo

AU - Lania, Andrea

AU - Palou, Juan

AU - Algaba, Ferran

AU - Villavicencio, Humberto

AU - Colpi, Giovanni Maria

AU - Decobelli, Ottavio

AU - Salvioni, Roberto

AU - Pizzocaro, Giorgio

AU - Rigatti, Patrizio

AU - Rocco, Francesco

PY - 2007/8

Y1 - 2007/8

N2 - Purpose: We performed a long-term evaluation of conservative surgical treatment of benign Leydig cell tumor. Materials and Methods: A multicenter retrospective clinical study was performed at 6 European centers. Case files of all patients diagnosed with Leydig cell tumor and treated with conservative surgery were examined. Patients underwent physical examination, hormone and tumor marker assays, scrotal and abdominal ultrasound, chest x-ray, and an endocrinological examination. Results: From 1987 to 2006, 22 patients with Leydig cell tumor underwent conservative surgery. Mean patient age was 35 years (range 5 to 61). Mean followup was 47 months (range 1 to 230). No local recurrence or metastasis was observed. Patients presented with a palpable testicular nodule (3 patients, 13.7%) or a nodule diagnosed by ultrasound (15 patients, 68.2%), gynecomastia (2 patients, 9.1%), precocious pseudopuberty (1 patient, 4.5%) or scrotal pain (1 patient, 4.5%). Three patients were monorchid after contralateral orchiectomy for inguinal hernia repair (1 patient, 28 years before surgery) and nonseminomatous germ cell tumor (2 patients, 1 month and 6 years before surgery). Diagnosis after frozen section examination was Leydig cell tumor in 20 of 22 cases (91.0%). Mean histological size of the nodule was 1.11 cm (range 0.5 to 2.5). Preoperative FSH and LH levels were high in 4 patients. Tumor markers were normal before and after surgery. Followup was conducted for all patients every 3 to 6 months with physical examination, tumor markers, scrotal and abdominal ultrasound, chest x-ray. Six patients (27.3%) underwent abdominal computerized tomography. Conclusions: When diagnosed early Leydig cell tumors present a favorable followup. In select cases with motivated patients, conservative surgery proved to be a feasible and safe choice.

AB - Purpose: We performed a long-term evaluation of conservative surgical treatment of benign Leydig cell tumor. Materials and Methods: A multicenter retrospective clinical study was performed at 6 European centers. Case files of all patients diagnosed with Leydig cell tumor and treated with conservative surgery were examined. Patients underwent physical examination, hormone and tumor marker assays, scrotal and abdominal ultrasound, chest x-ray, and an endocrinological examination. Results: From 1987 to 2006, 22 patients with Leydig cell tumor underwent conservative surgery. Mean patient age was 35 years (range 5 to 61). Mean followup was 47 months (range 1 to 230). No local recurrence or metastasis was observed. Patients presented with a palpable testicular nodule (3 patients, 13.7%) or a nodule diagnosed by ultrasound (15 patients, 68.2%), gynecomastia (2 patients, 9.1%), precocious pseudopuberty (1 patient, 4.5%) or scrotal pain (1 patient, 4.5%). Three patients were monorchid after contralateral orchiectomy for inguinal hernia repair (1 patient, 28 years before surgery) and nonseminomatous germ cell tumor (2 patients, 1 month and 6 years before surgery). Diagnosis after frozen section examination was Leydig cell tumor in 20 of 22 cases (91.0%). Mean histological size of the nodule was 1.11 cm (range 0.5 to 2.5). Preoperative FSH and LH levels were high in 4 patients. Tumor markers were normal before and after surgery. Followup was conducted for all patients every 3 to 6 months with physical examination, tumor markers, scrotal and abdominal ultrasound, chest x-ray. Six patients (27.3%) underwent abdominal computerized tomography. Conclusions: When diagnosed early Leydig cell tumors present a favorable followup. In select cases with motivated patients, conservative surgery proved to be a feasible and safe choice.

KW - early diagnosis

KW - Leydig cell tumor

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=34447274022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447274022&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2007.03.108

DO - 10.1016/j.juro.2007.03.108

M3 - Article

C2 - 17561156

AN - SCOPUS:34447274022

VL - 178

SP - 507

EP - 511

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -